Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.
Resources & Support
References
First Author
Ma, Y
Title
Identification and assessment of TCR-T cells targeting an epitope conserved in SARS-CoV-2 variants for the treatment of COVID-19.
Citation
International immunopharmacology; 2022 Nov; 112 pg109283
PubMed ID
Product Cited
Cross-Reactivity
Applications
First Author
Karagiannis, F
Title
Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19.
Citation
Nature; 2022 Sep; 609(7928) pg801-807
PubMed ID
First Author
Sasaki, K
Title
Activated-memory T cells influence naïve T cell fate: a noncytotoxic function of human CD8 T cells.
Citation
Communications biology; 2022 Jun 29; 5(1) pg634
PubMed ID
Product Cited
Cross-Reactivity
Applications
First Author
Kim, S
Title
Acoustofluidic Stimulation of Functional Immune Cells in a Microreactor.
Citation
Advanced science (Weinheim, Baden-Wurttemberg, Germany); 2022 Jun; 9(16) pg2105809
PubMed ID
Product Cited
Cross-Reactivity
Applications
First Author
Kalbasi, A
Title
Potentiating adoptive cell therapy using synthetic IL-9 receptors.
Citation
Nature; 2022 Jul; 607(7918) pg360-365
PubMed ID
First Author
Wang, W
Title
Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint Inhibitors.
Citation
Advanced science (Weinheim, Baden-Wurttemberg, Germany); 2022 Aug; 9(22) pge2105810
PubMed ID
First Author
Schad, S E
Title
Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions.
Citation
The Journal of experimental medicine; 2022 Jun 6; 219(6)
PubMed ID
Product Cited
Cross-Reactivity
Applications
First Author
Wu, H
Title
The IL-21-TET2-AIM2-c-MAF pathway drives the T follicular helper cell response in lupus-like disease.
Citation
Clinical and translational medicine; 2022 Mar; 12(3) pge781
PubMed ID
First Author
Bishop, E L
Title
1,25-Dihydroxyvitamin D3 suppresses CD4+ T-cell effector functionality by inhibition of glycolysis.
Citation
Immunology; 2022 Jul; 166(3) pg299-309
PubMed ID
Product Cited
Cross-Reactivity
Applications
First Author
Riise, J
Title
Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination.
Citation
British journal of haematology; 2022 Jun; 197(6) pg697-708
PubMed ID
Product Cited
Cross-Reactivity
Applications
showing 10 of 746
Quick Order: Upload CSV Instructions
Navigate to the CSV file of PeproTech products on your computer. Click on the file name to highlight it. Then, click "Open" in the dialog box. Items will load on the Quick Order form.
Coming Soon
This feature is coming soon.